Case-control study

A study that compares people who have a condition with similar people who do not, looking back to find differences that might explain it.

Also called: case control study, nested case-control

Related words cohort study

Topics Research

Questions people ask

How can I take part in a Crohn's clinical trial?

The NHS suggests asking your doctor or a patient organisation about trials you may be eligible for. You can also search the NIHR's Be Part of Research website for UK studies and contact research teams directly. Registries such as ISRCTN and ClinicalTrials.gov list studies and their results. Crohn's & Colitis UK explains how new medicines are tested before they are licensed.

Sources

How common is Crohn's disease in the UK?

Estimates vary with how cases are counted. Research funded by Crohn's & Colitis UK found about 1 in 123 people in the UK live with Crohn's or colitis, over half a million people. A large GP-records study found about 276 in every 100,000 people had Crohn's at the end of 2018, with new cases in teenagers almost doubling.

Sources

How do I take part in Crohn's research?

Ask your IBD team whether your hospital is running any studies. You can also search the NIHR's Be Part of Research website, which lists UK studies currently recruiting people with Crohn's. The IBD BioResource invites people with Crohn's or colitis to join a national panel and be contacted about future studies. Crohn's & Colitis UK also lists ways to help shape research, such as patient and public involvement.

Sources

What is a Cochrane review and why does it matter?

Cochrane reviews are systematic reviews: researchers find every good trial on a question, judge how reliable each one is and combine the results. They also grade how certain the evidence is. For Crohn's, Cochrane has found strong evidence for some treatments, such as vedolizumab, and too little evidence to judge others, such as treatments for fatigue.

Sources

Is Crohn's disease genetic?

Partly. In 2001 researchers found the first gene firmly linked to Crohn's, NOD2, which helps the immune system recognise bacteria. Later large studies found many more gene regions, each adding a small amount of risk, and many are shared with other immune conditions. Having these gene changes does not mean you will get Crohn's; gut bacteria and environment also play a part.

Sources

Where to read more

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

The Lancet Systematic review Dec 2017 For professionals

A review of population studies from around the world. In Western countries the number of new cases is levelling off but more than 0.3% of people now live with IBD. In newly industrialised countries in Asia, Africa and South America, new cases are rising quickly as lifestyles become more Western.

Topics About Crohn's disease Research

Jargon explained systematic review incidence prevalence population-based study

Clinical trials

NHS Web page Dec 2022 For patients

The NHS explains what a clinical trial is and how to find one. It suggests asking your doctor or a patient organisation, and points to the Be Part of Research website, where you can search UK studies and contact researchers.

Topics Research

Jargon explained clinical trial randomised

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

The Lancet Study Dec 2017 Patients and professionals

CALM compared deciding treatment on symptoms alone with 'tight control', where treatment was stepped up if blood or poo tests (CRP and faecal calprotectin) showed inflammation even when people felt fine. After 48 weeks, 46% in the tight control group had a healed bowel lining compared with 30% in the symptom-only group. It is a cornerstone of the 'treat to target' approach.

Topics Monitoring Biologics and newer medicines Research

Jargon explained tight control faecal calprotectin CRP mucosal healing treat to target

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

The Lancet Study May 2022 Patients and professionals

Two trials testing risankizumab (Skyrizi) drips to bring active Crohn's under control, including in people for whom other biologics had failed. Risankizumab led to more remissions, and more improvement seen on camera tests of the bowel, at 12 weeks than placebo, and was generally well tolerated.

Topics Biologics and newer medicines

Jargon explained induction phase 3 trial endoscopic response

The incidence and prevalence of inflammatory bowel disease in UK primary care: a retrospective cohort study of the IQVIA Medical Research Database

BMC Gastroenterology Data Mar 2021 For professionals

Another big UK GP-records study, covering 2006 to 2016. It found IBD rose by about a third over that time to roughly 1.4% of patients, higher than earlier estimates. The authors point out that the answer depends heavily on how a 'case' is defined, which may explain why older figures were lower.

Topics About Crohn's disease Research

Jargon explained retrospective cohort study prevalence incidence

Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study

BMJ Open via PubMed Central Study Jul 2020 For professionals

A study of more than 11 million people's GP records from 2000 to 2018 tracking new IBD diagnoses in the UK. It found new cases in adults were stable or falling, but UK rates are among the highest reported anywhere, with a large rise in new diagnoses among teenagers.

Topics About Crohn's disease Research

Jargon explained incidence prevalence cohort study primary care

Be Part of Research

NIHR Tool For patients

The NHS research service's search tool for finding health studies to take part in across the UK. Searching for Crohn's disease lists studies currently recruiting, with who can join and where. A good first stop if you want to volunteer for a trial.

Topics Research

Jargon explained clinical trial recruiting

Dietary interventions for induction and maintenance of remission in inflammatory bowel disease

Cochrane Systematic review Feb 2019 Patients and professionals

Reviewed trials of special diets (such as low-sugar, low-red-meat or exclusion diets) for Crohn's and colitis. The effects were uncertain and no firm conclusions could be drawn. The authors say experts need to agree what the diets should contain and more trials are needed.

Topics Diet and nutrition

Jargon explained dietary intervention randomised controlled trial

Diets for inducing and maintaining remission in inflammatory bowel disease (IBD)

Cochrane Systematic review Feb 2019 Patients and professionals

A Cochrane review of 18 trials that tested cutting down or cutting out foods thought to provoke IBD symptoms. The authors found the evidence too weak to say whether any of these diets help bring on or keep remission, and called for better trials. This summary dates from 2019.

Topics Diet and nutrition Research

Jargon explained remission exclusion diet randomised controlled trial

Search everything for "case-control study"